These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia. Arteaga CL Semin Oncol; 2002 Oct; 29(5 Suppl 14):3-9. PubMed ID: 12422308 [TBL] [Abstract][Full Text] [Related]
4. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. Arteaga CL J Clin Oncol; 2001 Sep; 19(18 Suppl):32S-40S. PubMed ID: 11560969 [TBL] [Abstract][Full Text] [Related]
5. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors. Rowinsky EK Annu Rev Med; 2004; 55():433-57. PubMed ID: 14746530 [TBL] [Abstract][Full Text] [Related]
6. [Epidermal growth factor receptors (EGFR): a new target for anticancer therapy]. Gainet M; Guardiola E; Dufresne A; Pivot X Cancer Radiother; 2003 Jun; 7(3):195-9. PubMed ID: 12834777 [TBL] [Abstract][Full Text] [Related]
7. Rational bases for the development of EGFR inhibitors for cancer treatment. Bianco R; Gelardi T; Damiano V; Ciardiello F; Tortora G Int J Biochem Cell Biol; 2007; 39(7-8):1416-31. PubMed ID: 17596994 [TBL] [Abstract][Full Text] [Related]
11. The role of the epidermal growth factor receptor in the treatment of colorectal carcinoma. Waxman ES; Herbst RS Semin Oncol Nurs; 2002 May; 18(2 Suppl 2):20-9. PubMed ID: 12053861 [TBL] [Abstract][Full Text] [Related]
12. An update on epidermal growth factor receptor inhibitors. Modi S; Seidman AD Curr Oncol Rep; 2002 Jan; 4(1):47-55. PubMed ID: 11734113 [TBL] [Abstract][Full Text] [Related]
13. The ErbB receptor family: a therapeutic target for cancer. de Bono JS; Rowinsky EK Trends Mol Med; 2002; 8(4 Suppl):S19-26. PubMed ID: 11927283 [TBL] [Abstract][Full Text] [Related]
14. Anti-epidermal growth factor receptor drugs in cancer therapy. Ciardiello F; Tortora G Expert Opin Investig Drugs; 2002 Jun; 11(6):755-68. PubMed ID: 12036420 [TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers. Roskoski R Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458 [TBL] [Abstract][Full Text] [Related]
16. Targeting the epidermal growth factor receptor (EGFR)--a new therapeutic option in oncology? Mamot C; Rochlitz C Swiss Med Wkly; 2006 Jan; 136(1-2):4-12. PubMed ID: 16597093 [TBL] [Abstract][Full Text] [Related]
17. Rational design of potent and selective EGFR tyrosine kinase inhibitors as anticancer agents. Ghosh S; Liu XP; Zheng Y; Uckun FM Curr Cancer Drug Targets; 2001 Aug; 1(2):129-40. PubMed ID: 12188886 [TBL] [Abstract][Full Text] [Related]